Recombinant cytokines Aspects to consider to supercharge your cell culture

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=PbZOX0C6gQw

Presented By: Dr. Anne Kiesewetter • Speaker Biography: Anne Kiesewetter Ph.D. graduated from the University of Cologne, Germany in 2019 with a Ph.D. in biology and molecular medicine. Her primary research interest throughout her education and training has been in immunology and ophthalmology. After two years working as a Field Application Specialist training customers on cytokine multiplex assays, she joined Miltenyi Biotec as a Product Manager for Cytokines and Cell Culture Reagents. • Webinar: Recombinant cytokines - Aspects to consider to supercharge your cell culture • Webinar Abstract: Recombinant cytokines and growth factors are essential components for cell culture. Since they are so widely used, it is worth taking a closer look at them and understand their characteristics. • When it comes to cytokine dosing, the biological activity is a crucial factor to consider. Biological activity is the specific effect of a recombinant cytokine on cells. It is neither a constant nor an absolute value. Ignoring this aspect of cytokine dosing can lead to unforeseen problems and prevent you from realizing the full potential of your cell culture. • Join us for this webinar to take a deep dive into what cytokine activity is and how it is measured in bioassays. Discover optimal cytokine dosing strategies, to improve your cell culture’s reproducibility while effectively managing costs. • Earn PACE Credits: • 1. Make sure you’re a registered member of Labroots (https://www.labroots.com/ms/webinar/r...) • 2. Watch the webinar on YouTube or on the Labroots Website (https://www.labroots.com/ms/webinar/r...) • 3. Click Here to get your PACE credits (Expiration date – 04/05/2025): (https://www.labroots.com/credit/pace-...) • Labroots on Social: • Facebook: / labrootsinc • Twitter: / labroots • LinkedIn: / labroots • Instagram: / labrootsinc • Pinterest: / labroots • SnapChat: labroots_inc

#############################

New on site